Quest Diagnostics Incorporated

Healthcare · Medical - Diagnostics & Research

Overall research band Mixed

Quality Weak

Valuation Strong

Balance sheet Very weak

Market confirmation Exceptional

One-minute company read

What this report can tell you now

What the company does

Quest Diagnostics Incorporated is a leading provider of diagnostic testing, information, and related services, founded in 1967 and headquartered in Secaucus, New Jersey. The company develops and delivers a wide range of diagnostic information services, including routine, advanced clinical, and anatomic pathology testing, primarily under the Quest Diagnostics brand and through specialized units such as AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum. Quest Diagnostics serves a diverse client base that includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other healthcare entities. Its services are delivered via an extensive network of laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals. The company also provides risk assessment services for the life insurance industry and offers information technology solutions to healthcare organizations and clinicians, generating revenue through the provision of these diagnostic and IT services.

The current research profile is Mixed Setup, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC9.1%Model input; read with the evidence status and period context.

Operating margin14.5%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years0.6%Model input; read with the evidence status and period context.

FCF margin12.3%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.